Literature DB >> 31172427

Variation in Blood and Colorectal Epithelia's Key Trace Elements Along with Expression of Mismatch Repair Proteins from Localized and Metastatic Colorectal Cancer Patients.

Ali Ghorbani Ranjbary1, Jalil Mehrzad2, Hesam Dehghani3,4, Abbas Abdollahi5, Saman Hosseinkhani6.   

Abstract

Colorectal cancer (CRC) is an increasingly common medical issue affecting millions worldwide, and contribution of the body's trace elements to CRC is arguable. The concentrations and buffered status of selenium, iron, copper, zinc, and phosphorus in blood and large intestinal tissues of CRC patients are, respectively, variable and vital for cell physiology. The aim of this study was to assess selenium, iron, copper, zinc, and phosphorus variations in blood and colorectal epithelia along with examining the expression of mismatch repair proteins in CRC patients with/without metastasis for potential diagnosis/therapy. Concentrations of selenium, iron, copper, zinc, and phosphorus in blood of healthy versus CRC patients and colorectal epithelia (adenocarcinomatous versus non-adenocarcinomatous/control) were measured in 40 CRC patients (55.87 ± 11.9 years old) with/without metastasis before surgery using ICP-OES. Mismatch repair (MMR) protein expression was analyzed through histopathological/immunohistochemistry assays, which was sparse in 5 CRC patient's colorectal tissues (12%). Compared with healthy individuals, blood and colorectal tissue's levels of phosphorus, copper, and iron were significantly higher in the CRC patients, and more pronounced in metastatic CRC patients; conversely, blood and colorectal tissue's selenium levels were significantly lower in metastatic patients. Unlike blood zinc, cancerous colorectal tissue's zinc concentration was significantly lower in CRC patients compared to healthy control cohorts. There was no significant difference on the measured elements in samples from CRC patients with MMR- compared to CRC patients with MMR+. Receiver operating characteristic analysis revealed a correlation of blood iron, zinc, copper, and phosphorus to CRC, and inappropriately low levels of blood and colorectal selenium correlated with exacerbated metastasis. Altered levels of selenium, iron, copper, zinc, and phosphorus in vivo may impact the pathogenesis and detection of CRC, and their diagnostic/therapeutic potential in CRC would be revealing.

Entities:  

Keywords:  Colorectal cancer; Metastasis; Oncoproteins; Trace elements; Tumor biology and biomarkers

Mesh:

Substances:

Year:  2019        PMID: 31172427     DOI: 10.1007/s12011-019-01749-9

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  4 in total

1.  Multivariate Investigation of Toxic and Essential Metals in the Serum from Various Types and Stages of Colorectal Cancer Patients.

Authors:  Mian H R Mahmood; Muhammad Abdul Qayyum; Farhan Yaseen; Tahir Farooq; Zahid Farooq; Muhammad Yaseen; Ahmad Irfan; Khawaja Muddassir; Muhammad Nadeem Zafar; Muhammad Tariq Qamar; Arshad Mehmood Abbasi; Hai-Yang Liu
Journal:  Biol Trace Elem Res       Date:  2021-02-26       Impact factor: 3.738

2.  Superparamagnetic Iron Oxide Nanoparticles Induce Apoptosis in HT-29 Cells by Stimulating Oxidative Stress and Damaging DNA.

Authors:  Ali Ghorbani Ranjbary; Golnaz Karbalaei Saleh; Mohammadreza Azimi; Fatemeh Karimian; Jalil Mehrzad; Javad Zohdi
Journal:  Biol Trace Elem Res       Date:  2022-04-22       Impact factor: 3.738

3.  Key Intermediate Species Reveal the Copper(II)-Exchange Pathway in Biorelevant ATCUN/NTS Complexes.

Authors:  Radosław Kotuniak; Marc J F Strampraad; Karolina Bossak-Ahmad; Urszula E Wawrzyniak; Iwona Ufnalska; Peter-Leon Hagedoorn; Wojciech Bal
Journal:  Angew Chem Int Ed Engl       Date:  2020-05-12       Impact factor: 15.336

4.  Apoptosis Induced by Ziziphora tenuior Essential Oil in Human Colorectal Cancer Cells.

Authors:  Mohammadreza Azimi; Jalil Mehrzad; Armita Ahmadi; Elnaz Ahmadi; Ali Ghorbani Ranjbary
Journal:  Biomed Res Int       Date:  2021-07-22       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.